Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply

Aliment Pharmacol Ther. 2021 Sep;54(6):852-853. doi: 10.1111/apt.16568.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Aspirin / therapeutic use
  • Carcinoma, Hepatocellular* / epidemiology
  • Carcinoma, Hepatocellular* / prevention & control
  • Chemoprevention
  • Humans
  • Liver Neoplasms* / epidemiology
  • Liver Neoplasms* / prevention & control

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin